Visas 1 - 5 av 5 resultat för sökning 'Seyed Reza Mousavi (13223324)', Sökningstid: 0,01s Förfina resultatet
  1. 1
    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites.

    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites. av Seyed Reza Mousavi (13223324)

    Publicerad 2025
    Lägg till i favoriter
    Sparad:
  2. 2
    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58].

    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58]. av Seyed Reza Mousavi (13223324)

    Publicerad 2025
    Lägg till i favoriter
    Sparad:
  3. 3
    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites.

    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites. av Seyed Reza Mousavi (13223324)

    Publicerad 2025
    Lägg till i favoriter
    Sparad:
  4. 4
    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites. av Seyed Reza Mousavi (13223324)

    Publicerad 2025
    Lägg till i favoriter
    Sparad:
  5. 5
    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites. av Seyed Reza Mousavi (13223324)

    Publicerad 2025
    Lägg till i favoriter
    Sparad:

Sökverktyg: